MRI characteristics of BRCA-associated breast cancers.

نویسندگان

  • A K Kelekar
  • S Mukherjee
  • C Mitri
  • F Khan
  • W Ducaine
  • L Dohany
  • D Zakalik
چکیده

1596 Background: Magnetic resonance imaging (MRI) is the preferred imaging modality for screening and diagnosis of breast cancer in BRCA-1and BRCA-2 mutation carriers. However, there is limited data on the radiographic features of BRCA1/2-positive breast cancers on MRI. This study evaluates the MRI characteristics of BRCA1/2 -related breast cancers. METHODS All female BRCA mutation carriers with a biopsy proven breast cancer, imaged with MRI for screening or preoperative evaluation at William Beaumont hospital between April 2002 until January 2011, were included in the study. A total of 47 mutation carriers were identified.All MRI examinations were retrospectively evaluated by an independent radiologist for the following characteristics: shape, margin, enhancement, T2 intratumoral intensity. RESULTS A majority of BRCA- associated breast tumors were morphologically irregular, hypodense lesions on MRI with heterogeneous enhancement. No statistically significant differences were noted among the BRCA-1 and -2 mutations carriers. CONCLUSIONS Previous studies have reported that BRCA-associated breast cancers demonstrate morphological characteristics that resemble benign tumors i.e.round shape and smooth margins. Our study however, showed features more typical of malignant lesions i.e. irregular shape and margin. Low T2 intratumoral intensity tumors were commonly seen in our cohort, although BRCA1 patients often develop triple negative tumors which typically are high intensity. These differences may be explained by small sample size or population differences. Future reasearch is needed with larger patient cohorts to elucidate the unique MRI characteristics of BRCA- related cancers. [Table: see text].

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Association between BRCA Mutation Status, Pathological Findings, and Magnetic Resonance Imaging Features in Patients with Breast Cancer at Risk for the Mutation

PURPOSE We investigated the relationship between BRCA mutations, pathological findings, and magnetic resonance imaging (MRI) features in patients with breast cancer at risk for the mutation. METHODS Genetic testing for BRCA mutations was performed in 275 breast cancer patients with at least one risk factor for the mutation. Using the breast imaging reporting and data system MR lexicon, morpho...

متن کامل

Towards Evidence-Based Management of Inherited Breast and Breast-Ovarian Cancer

Inherited breast-ovarian cancer was described in 1866. The underlying genetic defects in BRCA1/2 were demonstrated 128 years later. We now have 10 years of experience with genetic testing in BRCA kindreds. The majority of breast cancer kindreds (familial breast cancer) do not demonstrate ovarian cancer and are not associated with BRCA mutations. The effect of early diagnosis and treatment is mo...

متن کامل

BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: a population-based study.

Early age at onset is generally considered an indicator of genetic susceptibility to breast cancer. To address both the proportion of early-onset breast cancer associated with BRCA-1 or BRCA-2 germline mutation and the contribution of germline mutations to the clinical features and outcome of these tumors, we analyzed molecular status and clinical variables of a population-based sample of 66 It...

متن کامل

BRCA 1/2-Mutation Related and Sporadic Breast and Ovarian Cancers: More Alike than Different

No longer is histology solely predictive of cancer treatment and outcome. There is an increasing influence of tumor genomic characteristics on therapeutic options. Both breast and ovarian cancers are at higher risk of development in patients with BRCA 1/2-germline mutations. Recent data from The Cancer Genome Atlas and others have shown a number of genomic similarities between triple negative b...

متن کامل

Imaging features of estrogen-negative breast cancers: a correlation study with human epidermal growth factor type II overexpression

Background: Estrogen-negative breast cancers have different clinical course, prognostic features and treatment response in comparison to estrogen receptor-positive (ER-positive) breast cancers. Human epidermal growth factor receptor 2 (HER2) oncoprotein has found to have a pivotal role in natural cell growth and cell division and is suggested to be directly related to tumor invasiveness in brea...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology

دوره 29 15_suppl  شماره 

صفحات  -

تاریخ انتشار 2011